RVTY
Get informed when a big investor buys or sells
+ FollowOvervalued by 61.3% based on the discounted cash flow analysis.
| Market cap | $16.90 Billion |
|---|---|
| Enterprise Value | $19.22 Billion |
| Dividend Yield | $0.28 (0.18%) |
| Earnings per Share | $2.08 |
| Beta | 1.09 |
| Outstanding Shares | 111,746,000 |
| P/E Ratio | 72.16 |
|---|---|
| PEG | -1829.29 |
| Price to Sales | 5.83 |
| Price to Book Ratio | 2.37 |
| Enterprise Value to Revenue | 6.6 |
| Enterprise Value to EBIT | 54.01 |
| Enterprise Value to Net Income | 80 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.46 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4904▼ 1150.33% |
|---|---|
| Total Calls | 78,500▲ 23.10% |
| Total Puts | 38,500▼ 94.97% |
Holdings and activity of institutional investors.
| Ownership % | 102.96%▼ 0.27% |
|---|---|
| Total Invested | $12.80B▲ 26.56% |
| Investors Holding | 554▲ 42.00% |
No data
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...